References
1. Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Global oncology. 2020;6:1063-75.
2. Nenclares P, Harrington K. The biology of cancer. Medicine. 2020;48(2):67-72.
3. ArefNezhad R, Rezaei‐Tazangi F, Roghani‐Shahraki H, Goleij P, Zare N, Motedayyen H, et al. Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer? Cell Biology International. 2023;47(4):714-9.
4. Kontomanolis EN, Koutras A, Syllaios A, Schizas D, Mastoraki A, Garmpis N, et al. Role of oncogenes and tumor-suppressor genes in carcinogenesis: a review. Anticancer research. 2020;40(11):6009-15.
5. Fathi F, Saidi RF, Banafshe HR, Arbabi M, Lotfinia M, Motedayyen H. Changes in immune profile affect disease progression in hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology. 2022;36:03946320221078476.
6. Wu S, Zhu W, Thompson P, Hannun YA. Evaluating intrinsic and non-intrinsic cancer risk factors. Nature communications. 2018;9(1):1-12.
7. Hasan-Abad AM, Adabi E, Sadroddiny E, Khorramizadeh MR, Mazlomi MA, Mehravar S, et al. Functional Deimmunization of Interferon Beta-1b by Identifying and Silencing Human T Cells Epitopes. Iranian Journal of Allergy, Asthma and Immunology. 2019:427-40.
8. Mavragani IV, Nikitaki Z, Kalospyros SA, Georgakilas AG. Ionizing radiation and complex DNA damage: from prediction to detection challenges and biological significance. Cancers. 2019;11(11):1789.
9. Rezaei-Tazangi F, Roghani-Shahraki H, Khorsand Ghaffari M, Abolhasani Zadeh F, Boostan A, ArefNezhad R, et al. The therapeutic potential of common herbal and nano-based herbal formulations against ovarian cancer: New insight into the current evidence. Pharmaceuticals. 2021;14(12):1315.
10. Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and cancer: friends or faux? International Journal of Molecular Sciences. 2020;21(9):3115.
11. Sisakht M, Mahmoodzadeh A, Zahedi M, Rostamzadeh D, Hasan-Abad AM, Atapour A. In silico approach for designing a novel recombinant fusion protein as a candidate vaccine against hpv. Current Proteomics. 2021;18(4):549-62.
12. Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: Signaling pathways and targeted intervention. Signal transduction and targeted therapy. 2021;6(1):1-46.
13. Kay M, Hasan-Abad AM, Hojati Z, Korbekandi H. Targeted mutations in Val101 and Arg27 interferon beta protein increase its transcriptional and translational activities. Cytokine. 2016;78:1-6.
14. Abdel-Salam IM, Abou-Bakr A, Ashour M. Cytotoxic effect of aqueous ethanolic extract of Luffa cylindrica leaves on cancer stem cells CD44+/24-in breast cancer patients with various molecular sub-types using tissue samples in vitro. Journal of ethnopharmacology. 2019;238:111877.
15. Baraya YuSaB, Wong KK, Yaacob NS. The immunomodulatory potential of selected bioactive plant-based compounds in breast cancer: a review. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2017;17(6):770-83.
16. Chen H, Yang J, Yang Y, Zhang J, Xu Y, Lu X. The natural products and extracts: anti‐triple‐negative breast cancer in vitro. Chemistry & Biodiversity. 2021;18(7):e2001047.
17. Chowjarean V, Sadabpod K. Antiproliferative effect of Grammatophyllum speciosum ethanolic extract and its bioactive compound on human breast cancer cells. The Scientific World Journal. 2021;2021.
18. Chellappan DK, Chellian J, Ng ZY, Sim YJ, Theng CW, Ling J, et al. The role of pazopanib on tumour angiogenesis and in the management of cancers: A review. Biomedicine & Pharmacotherapy. 2017;96:768-81.
19. Kasiri N, Rahmati M, Ahmadi L, Eskandari N, Motedayyen H. Therapeutic potential of quercetin on human breast cancer in different dimensions. Inflammopharmacology. 2020;28:39-62.
20. Churiyah C, Ningsih S, Firdayani F. The cytotoxic, apoptotic induction, and cell cycle arrest activities of solanum nigrum L. ethanolic extract on MCF-7 human breast cancer cell. Asian Pacific Journal of Cancer Prevention: APJCP. 2020;21(12):3735.
21. Keyvani V, Riahi E, Yousefi M, Esmaeili S-A, Shafabakhsh R, Moradi Hasan-Abad A, et al. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies. Frontiers in pharmacology. 2022;13:823572.
22. Alharbi KS, Shaikh MAJ, Almalki WH, Kazmi I, Al-Abbasi FA, Alzarea SI, et al. PI3K/Akt/mTOR pathways inhibitors with potential prospects in non-small-cell lung cancer. Journal of Environmental Pathology, Toxicology and Oncology. 2022;41(4).
23. Colamba Pathiranage V, Lowe JN, Rajagopalan U, Ediriweera MK, Senathilake K, Piyathilaka P, et al. Hexane extract of Garcinia quaesita fruits induces apoptosis in breast cancer stem cells isolated from triple negative breast cancer cell line MDA-MB-231. Nutrition and Cancer. 2021;73(5):845-55.
24. Collard M, Gallagher PE, Tallant EA. A polyphenol-rich extract from muscadine grapes inhibits triple-negative breast tumor growth. Integrative Cancer Therapies. 2020;19:1534735420917444.
25. Gupta G, Al-Malki WH, Kazmi I, Thangavelu L, Gupta PK, Jha NK, et al. The role of HGF/MET in liver cancer. Future medicinal chemistry. 2021;13(21):1829-32.
26. Dandawate PR, Subramaniam D, Jensen RA, Anant S, editors. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Seminars in cancer biology; 2016: Elsevier.
27. Dhouibi R, Affes H, Salem MB, Hammami S, Sahnoun Z, Zeghal KM, et al. Screening of pharmacological uses of Urtica dioica and others benefits. Progress in biophysics and molecular biology. 2020;150:67-77.
28. Espinosa-Paredes DA, Cornejo-Garrido J, Moreno-Eutimio MA, Martínez-Rodríguez OP, Jaramillo-Flores ME, Ordaz-Pichardo C. Echinacea angustifolia DC extract induces apoptosis and cell cycle arrest and synergizes with paclitaxel in the MDA-MB-231 and MCF-7 human breast cancer cell lines. Nutrition and cancer. 2021;73(11-12):2287-305.
29. George BP, Chandran R, Thamburaj S, Parimelazhagan T. Combined Effect of Vaccinium nilgiriensis Bark Extract and 680nm Laser Irradiation in Inducing Breast Cancer Cell Death. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2021;21(2):207-13.
30. Graidist P, Martla M, Sukpondma Y. Cytotoxic activity of Piper cubeba extract in breast cancer cell lines. Nutrients. 2015;7(4):2707-18.
31. Guerra AR, Soares BI, Freire CS, Silvestre AJ, Duarte MF, Duarte IF. Metabolic effects of a Eucalyptus bark lipophilic extract on triple negative breast cancer and nontumor breast epithelial cells. Journal of Proteome Research. 2020;20(1):565-75.
32. Vinogradov S, Wei X. Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine. 2012;7(4):597-615.
33. Patra CR, Mukherjee S, Kotcherlakota R. Biosynthesized silver nanoparticles: a step forward for cancer theranostics? Nanomedicine. 2014;9(10):1445-8.
34. Mukherjee S, Patra CR. Therapeutic application of anti-angiogenic nanomaterials in cancers. Nanoscale. 2016;8(25):12444-70.
35. Mohammadi M, Moradi Hasan-Abad A, Dehghani P, Nabipour I, Roozbehani M, Hemphill A, et al. Dicentracin-Like from Asian sea bass fish and Moronecidine-Like from Hippocampus comes: Two candidate antimicrobial peptides against Leishmanina major infection. International Journal of Peptide Research and Therapeutics. 2021;27:769-78.
36. Caruso M, Colombo A, Fedeli L, Pavesi A, Quaroni S, Saracchi M, et al. Isolation of endophytic fungi and actinomycetes taxane producers. Annals of microbiology. 2000;50(1):3-14.
37. Weaver BA. How Taxol/paclitaxel kills cancer cells. Molecular biology of the cell. 2014;25(18):2677-81.
38. Hasan-Abad AM, Mohammadi M, Mirzaei H, Mehrabi M, Motedayyen H, Arefnezhad R. Impact of oligomerization on the allergenicity of allergens. Clinical and Molecular Allergy. 2022;20(1):1-10.
39. Aung TN, Qu Z, Kortschak RD, Adelson DL. Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. International journal of molecular sciences. 2017;18(3):656.
40. Singh S, Sharma B, Kanwar SS, Kumar A. Lead phytochemicals for anticancer drug development. Frontiers in plant science. 2016;7:1667.
41. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of natural products. 2020;83(3):770-803.
42. Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559.
43. Cragg GM, Pezzuto JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Medical Principles and Practice. 2016;25(Suppl. 2):41-59.
44. Seca AM, Pinto DC. Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. International journal of molecular sciences. 2018;19(1):263.
45. Tariq A, Sadia S, Pan K, Ullah I, Mussarat S, Sun F, et al. A systematic review on ethnomedicines of anti‐cancer plants. Phytotherapy Research. 2017;31(2):202-64.
46. Thakore P, Mani RK, Kavitha SJ. A brief review of plants having anti-cancer property. Int J Pharm Res Dev. 2012;3:129-36.
47. Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Frontiers in pharmacology. 2020;10:1614.
48. Jafri A, Amjad S, Bano S, Kumar S, Serajuddin M, Arshad M. Efficacy of nano-phytochemicals over pure phytochemicals against various cancers: Current trends and future prospects. Nanomaterials and environmental biotechnology. 2020:407-24.
49. Santos CD, Schier CJG. Colchicine, podophyllin, and the vinca alkaloids. Goldfrank’s toxicologic emergencies, Eleventh Edition, Eleventh New York: The McGraw-Hill Companies. 2019:501-10.
50. Zan L, Chen Q, Zhang L, Li X. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25. Bioengineered. 2019;10(1):374-82.
51. Kim J, Yoo J, Kim J, Kim S, Park J, Seok Y, et al. Anticancer effect of mountain ginseng. Evid Based Complement Alternat Med. 2020.
52. Garvin S, Öllinger K, Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer letters. 2006;231(1):113-22.
53. Lai H-W, Chien S-Y, Kuo S-J, Tseng L-M, Lin H-Y, Chi C-W, et al. The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin. Evidence-Based Complementary and Alternative Medicine. 2012;2012.
54. Xu J, Long Y, Ni L, Yuan X, Yu N, Wu R, et al. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC cancer. 2019;19(1):1-20.
55. Karatoprak GŞ, Küpeli Akkol E, Genç Y, Bardakcı H, Yücel Ç, Sobarzo-Sánchez E. Combretastatins: an overview of structure, probable mechanisms of action and potential applications. Molecules. 2020;25(11):2560.
56. Park Y, Woo SH, Seo SK, Kim H, Noh WC, Lee JK, et al. Ginkgetin induces cell death in breast cancer cells via downregulation of the estrogen receptor. Oncology Letters. 2017;14(4):5027-33.
57. Tripathi M, Reddy P, Rawat D. Noscapine and its analogues as anti-cancer agents. Chem Biol Interface. 2014;4:1-22.
58. Chen L, Wang H-J, Xie W, Yao Y, Zhang Y-S, Wang H. Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo. Molecular medicine reports. 2014;9(6):2447-52.
Table 1. List of the anticancer drug classes and active compounds in each class and common side effects.